Related Experiment Video
Updated: Jun 20, 2026
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
Biomarkers in cervical cancer
Eun-Kyoung Yim1, Jong-Sup Park
1Department of Obstetrics and Gynecology, Catholic University Medical College, 505 Banpodong, Seochogu, Seoul, 137-040, Republic of Korea.
Biomarker Insights
|August 20, 2009
Summary
Cervical cancer, often caused by human papillomavirus (HPV), remains a global health issue despite screening. Discovering new biomarkers is crucial for accurately detecting high-grade cervical disease and improving patient outcomes.
Area of Science:
- Oncology
- Virology
- Gynecology
Background:
- Cervical cancer is the second most common cancer in women globally.
- Human papillomavirus (HPV) is the primary cause of cervical cancer, with E6 and E7 oncoproteins driving disease progression.
- While Pap smear screening has reduced incidence and mortality, cervical cancer persists as a significant global health burden.
Purpose of the Study:
- To highlight the ongoing challenge in biomarker discovery for accurate detection of cervical carcinoma.
- To emphasize the need for improved diagnostic tools for high-grade cervical disease.
- To address the critical gap in clinical medicine and cytopathology for early and precise diagnosis.
Main Methods:
- Review of current literature on cervical cancer etiology and diagnosis.
- Analysis of the role of HPV oncoproteins in neoplastic progression.
- Discussion of the limitations of existing screening methods.
Main Results:
- HPV, particularly its E6 and E7 oncoproteins, is the key etiological factor.
- Pap smear screening has limitations in fully preventing cervical cancer.
- Accurate detection of high-grade cervical disease remains a diagnostic challenge.
Conclusions:
- Biomarker discovery is essential for improving the accuracy of cervical cancer diagnosis.
- Enhanced diagnostic strategies are needed to manage high-grade cervical disease effectively.
- Further research into novel biomarkers will aid in combating this global health challenge.
